meetings

2023 ASCO Annual Meeting; #ASCO23
July 27, 2023 · Brielle Gregory Collins, ASCO staff
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in breast cancer, lymphoma, multiple myeloma, brain tumors, and von Hippel-Lindau syndrome. Read More >>
ASCO ® Plenary Series
July 24, 2023 · Brielle Gregory Collins, ASCO staff
Read research from the July 2023 session of the ASCO Plenary Series, which highlights a study evaluating a potential maintenance therapy option for people with advanced or recurrent TP53 wild-type endometrial cancer. Read More >>
2023 ASCO Annual Meeting; #ASCO23
June 6, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. A study presented today shows that removing radiation therapy from the treatment plan for an aggressive form of lymphoma does not impact the risk of recurrence or overall survival. Read More >>
2023 ASCO Annual Meeting; #ASCO23
June 5, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. Research highlights from the day include using trastuzumab deruxtecan to treat HER2-expressing tumors and using CAR T-cell therapy to slow or stop multiple myeloma. Read More >>
2023 ASCO Annual Meeting; #ASCO23
June 4, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. Several notable studies will be presented today. Topics include radiation therapy in rectal cancer, osimertinib for lung cancer, vorasidenib for grade 2 glioma, nivolumab for Hodgkin lymphoma, and mirvetuximab soravtansine for ovarian cancer. Read More >>

Pages